SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-256038
Filing Date
2024-11-12
Accepted
2024-11-12 16:40:26
Documents
2
Group Members
AVICENNA LIFE SCI MASTER FUND LPAVICENNA LIFE SCI MASTER GP LLCINVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.RAYMOND DEBBANESIREN, L.L.C.ULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d910514dsc13ga.htm SC 13G/A 134843
2 EX-99.1 d910514dex991.htm EX-99.1 9937
  Complete submission text file 0001193125-24-256038.txt   146667
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Subject) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91334 | Film No.: 241449173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212-371-1717
Invus Global Management, LLC (Filed by) CIK: 0002005369 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A